Major Institution Ratings | Leerink Partners: Raises Johnson & Johnson target price to $265, optimistic about the company's growth prospects

格隆汇2026/05/13 15:14

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Golden Ten Data, May 13｜Leerink Partners has upgraded the rating of Johnson & Johnson from "Market Perform" to "Outperform", raising the 12-month target price from $252 to $265. The reason is the successive launch of several new drugs and the continued expansion of the company's oncology and immunology business, which has significantly accelerated its growth prospects.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Major Institution Ratings | Leerink Partners: Raises Johnson & Johnson target price to $265, optimistic about the company's growth prospects

You may also like

Crypto prices